Finance

Lists
Why is 9969 up 2,67%?
Dive Deeper
9969:HKG
InnoCare Pharma Ltd
12,32 HK$
+2,67%
(+0,32) 1D
16 қаз., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9969...
Open
12,20 HK$
High
12,64 HK$
Low
12,01 HK$
Mkt. cap
26,72 млрд
Avg. vol.
8,46 млн
Volume
7,54 млн
P/E ratio
28,00
52-wk high
16,20 HK$
52-wk low
9,65 HK$
EPS
0,44 HK$
No. of employees
1 мың
Open
12,20 HK$
High
12,64 HK$
Low
12,01 HK$
Mkt. cap
26,72 млрд
Avg. vol.
8,46 млн
Volume
7,54 млн
P/E ratio
28,00
52-wk high
16,20 HK$
52-wk low
9,65 HK$
EPS
0,44 HK$
No. of employees
1 мың
News stories
From web sources and news partners
About InnoCare Pharma Ltd
CEOJasmine Cui
Employees1,39 мың
Founded2015 ж. 03 қар.
Headquarters-
Sector-
Next call 7 күннен кейін
26 қаз., дс, 10:00
Fiscal period
Q3 2026
- / -
Revenue / Est. (CNY)
- / 691,21 млн
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
383,89 млн
1,26 млрд
528,63 млн
608,43 млн
Cost of goods sold
48,46 млн
66,11 млн
62,72 млн
56,27 млн
Cost of revenue
48,46 млн
66,11 млн
62,72 млн
56,27 млн
Research and development expenses
226,35 млн
275,57 млн
229,16 млн
267,92 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187,93 млн
243,50 млн
162,45 млн
205,62 млн
Operating expense
388,22 млн
560,08 млн
392,10 млн
476,27 млн
Total operating expenses
436,68 млн
626,19 млн
454,82 млн
532,54 млн
Operating income
-52,79 млн
633,39 млн
73,81 млн
75,89 млн
Other non operating income
26,02 млн
-26,67 млн
11,13 млн
-13,40 млн
EBT including unusual items
-33,60 млн
719,92 млн
104,85 млн
142,30 млн
EBT excluding unusual items
-8,17 млн
673,62 млн
101,24 млн
102,50 млн
Income tax expense
2,72 млн
3,79 млн
2,40 млн
5,07 млн
Effective tax rate
-8,09%
0,53%
2,29%
3,57%
Other operating expenses
-25,90 млн
40,29 млн
-320,57 м.
3,37 млн
Net income
-34,32 млн
706,88 млн
105,82 млн
140,54 млн
Net profit margin
-8,94%
56,12%
20,02%
23,10%
Earnings per share
-
-
-
-
Interest and investment income
44,67 млн
47,46 млн
30,69 млн
37,25 млн
Interest expense
-14,49 млн
-12,42 млн
-14,38 млн
-15,13 млн
Net interest expenses
30,17 млн
35,04 млн
16,30 млн
22,12 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-36,03 млн
652,95 млн
93,37 млн
94,23 млн
Gain or loss from assets sale
3,40 мың
-3,40 мың
-
-197,23 м.
AI content may include mistakes. Learn more
Google қолданбалары